1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Slovenia Pharmaceuticals and Healthcare Report Q2 2016

Slovenia Pharmaceuticals and Healthcare Report Q2 2016

  • March 2016
  • -
  • Business Monitor International
  • -
  • 79 pages

Includes 3 FREE quarterly updates

BMI View: Krka's exposure to Eastern European markets will continue to act as a drag on revenue growth.However, strong sales growth in Western Europe will mitigate the impact of revenue declines for the shortterm. We expect a continued focus on cost containment by European healthcare payers to moderate Krka'sgrowth outlook over the longer term, unless the company looks to geographically diversify its exposure.

Headline Expenditure Projections

- Pharmaceuticals: EUR671mn (USD745mn) in 2015 to EUR645mn (USD690mn) in 2016; -3.9% inlocal currency terms and -7.3% in US dollar terms. Forecasts revised downwards compared to previousquarter.

- Healthcare: EUR3.22bn (USD3.58bn) in 2015 to EUR3.25bn (USD3.48bn) in 2016; 0.9% in localcurrency terms and -2.8% in US dollar terms. Forecasts revised slightly downwards compared toprevious quarter.BMI Risk/Reward IndexSlovenia scores 56.0 out of a total of 100 in our Pharmaceutical Risk/Reward Index for Q216, up to 9thplace from 11th place in the previous quarter. Slovenia scores above the average for the region, which is52.6.

Table Of Contents

Slovenia Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Slovenia 2014-2020) 8
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Slovenia 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Slovenia 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Slovenia 2012-2020) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Slovenia 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Slovenia 2012-2020) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Slovenia 2014-2020) 31
Table: Pharmaceutical Trade Data And Forecasts local currency (Slovenia 2014-2020) 31
Industry Risk/Reward Index 32
Central And Eastern Europe Risk/Reward Index 32
Slovenia Risk/Reward Index 38
Rewards 38
Risks 38
Regulatory Review 40
Intellectual Property Issues 41
Pricing Regime 41
Reimbursement Regime 43
Market Overview 45
Healthcare Sector 46
Table: Healthcare Resources (Slovenia 2010-2015) 50
Table: Healthcare Personnel (Slovenia 2010-2015) 50
Table: Healthcare Activity (Slovenia 2010-2015) 51
Research and Development 51
Clinical Trials 51
Epidemiology 52
Competitive Landscape 55
Research-Based Industry 55
Table: Table: Multinational Market Activity 55
Generic Drugmakers 56
Company Profile 59
Krka 59
Lek (Novartis/Sandoz) 64
Demographic Forecast 68
Table: Population Headline Indicators (Slovenia 1990-2025) 69
Table: Key Population Ratios (Slovenia 1990-2025) 69
Table: Urban/Rural Population and Life Expectancy (Slovenia 1990-2025) 70
Table: Population By Age Group (Slovenia 1990-2025) 70
Table: Population By Age Group % (Slovenia 1990-2025) 71
Glossary 73
Methodology 75
Pharmaceutical Expenditure Forecast Model 75
Healthcare Expenditure Forecast Model 75
Notes On Methodology 76
Risk/Reward Index Methodology 77
Index Overview 78
Table: Pharmaceutical Risk/Reward Index Indicators 78
Indicator Weightings 79

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.